Gliclazide EP Impurity B
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144084 |
| CAS No | NA |
| Mol.F. | C8H16N4O2 |
| Mol.Wt. | 200.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144085 |
| CAS No | NA |
| Mol.F. | C14H11ClN4O5S2 |
| Mol.Wt. | 414.84 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144086 |
| CAS No | NA |
| Mol.F. | C13H9ClN4O6S2 |
| Mol.Wt. | 416.81g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144087 |
| CAS No | NA |
| Mol.F. | C28H34N8O4 |
| Mol.Wt. | 546.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144088 |
| CAS No | NA |
| Mol.F. | C25H30N8O2 |
| Mol.Wt. | 474.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144089 |
| CAS No | NA |
| Mol.F. | C28H33ClN8O3 |
| Mol.Wt. | 565.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144090 |
| CAS No | NA |
| Mol.F. | C28H32N8O4 |
| Mol.Wt. | 544.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144091 |
| CAS No | NA |
| Mol.F. | C25H28N8O4 |
| Mol.Wt. | 504.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144092 |
| CAS No | NA |
| Mol.F. | C20H15FN6O4 |
| Mol.Wt. | 422.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144093 |
| CAS No | NA |
| Mol.F. | C24H28N8O2 |
| Mol.Wt. | 460.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144094 |
| CAS No | NA |
| Mol.F. | C24H28N8O2 |
| Mol.Wt. | 460.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144095 |
| CAS No | NA |
| Mol.F. | C12H7ClN4O |
| Mol.Wt. | 258.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144096 |
| CAS No | NA |
| Mol.F. | C19H13FN6O4 |
| Mol.Wt. | 408.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144097 |
| CAS No | NA |
| Mol.F. | C24H26N8O4 |
| Mol.Wt. | 490.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144098 |
| CAS No | NA |
| Mol.F. | C24H26N8O4 |
| Mol.Wt. | 490.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144099 |
| CAS No | NA |
| Mol.F. | C24H26N8O4 |
| Mol.Wt. | 490.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |